Hip fracture device study pulled before it began

NCT ID NCT05559736

Terminated Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study was designed to test a new metal implant called the Artemis Proximal Femoral Nail for fixing a common type of hip fracture. The plan was to compare results from patients who received this implant to similar patients from the past who received other implants. However, the study was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artemis Proximal Femoral Nail (PFN) implant
What this could lead to: If successful, this could provide a safe and effective option for surgically fixing certain hip fractures.
What could go wrong: This trial was withdrawn before enrolling any participants, so no data is available. The device already has FDA clearance, but this pilot study was never conducted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORAL FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoral Fractures femoral neck fracture hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMORAL FRACTURE FEMORAL NECK FRACTURES INTERTROCHANTERIC FRACTURES

Contacts and locations

Locations

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, 21244, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.